Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network

Weber, Damien; Wang, Yucai; Miller, Robert; Villa, Salvador; Zaucha, Renata; Pica, Alessia; Poortmans, Philip; ANACAK, YAVUZ; Ozygit, Gokhan; Baumert, Birgitta; Haller, Guy; Preusser, Matthias; Li, Jing

doi:10.1093/neuonc/nou293

Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network

Copy For Citation

Weber D. C. , Wang Y., Miller R., Villa S., Zaucha R., Pica A., ...More

NEURO-ONCOLOGY, vol.17, no.4, pp.588-595, 2015 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 17 Issue: 4
Publication Date: 2015
Doi Number: 10.1093/neuonc/nou293
Title of Journal : NEURO-ONCOLOGY
Page Numbers: pp.588-595

Abstract

Background. Spinal myxopapillary ependymomas (MPEs) are slowly growing ependymal gliomas with preferential manifestation in young adults. The aim of this study was to assess the outcome of patients with MPE treated with surgery, radiotherapy (RT), and/or chemotherapy.